Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study

There’s a lot of excitement about PSMA based therapies and everyone is coming in asking about it. Helpful to see this article to include in the discussion with patients about what factors are associated with the best outcomes from this therapy so far.

Read the full article here

Related Articles